Initiative aims to enhance maternal health and birth outcomes; Wegovy success will help fund a vaccines initiative for respiratory diseases; new tactics aim to remove abortion from the 2024 ballot
CMS Launches Maternal Health Model to Address Maternal Health Crisis
A new model will support state Medicaid agencies in adopting a comprehensive approach to pregnancy, childbirth, and postpartum care for women with Medicaid and Children's Health Insurance Program (CHIP) coverage, according to CMS. Aimed at reducing adverse outcomes and disparities, the model focuses on personalized care, increased access to maternal health providers, and fostering connections to implement evidence-based practices. Each participating state Medicaid agency is eligible for up to $17 million during the 10-year period to address the maternal health crisis and enhance the overall maternity care experience.
Novo Nordisk Foundation Commits $265 Million to Initiative Improving Respiratory Disease Vaccines
The Novo Nordisk Foundation announced a commitment of approximately $265 million to establish the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI), according to Reuters. The initiative aims to advance vaccines for deadly respiratory diseases like tuberculosis, influenza, and group A streptococcus, which collectively contribute to over 2.5 million deaths annually. In partnership with the University of Copenhagen, NIVI will focus on generating immunity in the airway, addressing a critical gap in respiratory disease prevention. The funding is fueled by the success of Novo Nordisk's weight loss drug semaglutide (Wegovy), turning the foundation into a significant philanthropist and environmental, social, and governance (ESG) investor.
Conservatives Employ New Strategies to Thwart Abortion Ballot Measures
Anti-abortion activists and Republicans are implementing a range of strategies to prevent abortion-related issues from reaching the ballot in various states, according to Politico. These tactics include ad campaigns encouraging people not to sign petitions, legal challenges arguing against the clarity of proposed amendments, and legislative efforts to raise the threshold for ballot measures or alter the initiative process. The actions reflect concerns among anti-abortion groups about their ability to secure victories at the ballot box, particularly in the wake of recent successes by abortion-rights advocates in states like Kansas, Kentucky, Michigan, and Ohio.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Bimekizumab Shows Sustained Efficacy in Treating Axial Spondyloarthritis for 52 Weeks
April 30th 2024Results from a study presented at the Academy of Managed Care Pharmacy 2024 annual meeting demonstrated sustained efficacy of bimekizumab compared with placebo in patients with non-radiographic and radiographic axial spondyloarthritis (axSpA) at week 52.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More